Pekabex stock: Pekabex ends a subsidiary contract. What it means for Pekabex stock

Published on 10/22/2026 at 04:05 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Pekabex stock posted PLN 917.68 million revenue in the first half, up 0.47 percent year over year. Backlog hit PLN 2.37 billion.

Company updates and valuation

Pekabex reported a subsidiary contract termination in report 56/2026 dated October 5, 2026.
The order backlog reached PLN 2.37 billion at the end of June 2026.
Pekabex had a PLN 198.6 million market capitalization on October 21, 2026.

Pekabex, PLPKBEX00072, Illustration mit AI erstellt.

Pekabex (PLPKBEX00072) reported PLN 917.68 million in consolidated sales for the first half of 2026, up from PLN 913.34 million a year earlier. On October 5, 2026, Bankier reported the termination of a significant contract held by a Pekabex subsidiary.

What does the contract change mean?

The report came after Pekabex published its half-year figures on September 30, 2026. The group posted a consolidated operating loss of PLN 12.52 million in the first half, compared with an operating profit of PLN 9.08 million in the first half of 2025, according to Bankier.

The second quarter showed a sharper improvement in operating performance. Pekabex generated PLN 508.91 million in sales and PLN 7.40 million in EBITDA, while net income attributable to the parent company was a PLN 3.43 million loss, as reported by Parkiet.

How much work is in hand?

At the end of June 2026, Pekabex held an order backlog of PLN 2.37 billion. The figure included PLN 1.34 billion scheduled for the second half of 2026 and PLN 730 million for 2027, giving the company a defined revenue base beyond the reporting period.

The backlog was 16.00 percent higher than a year earlier, while first-half sales increased only 0.47 percent. That contrast leaves execution and project profitability as the central operating issue for the remainder of 2026.

When is the next report?

Trading-calendar information published by TradingView points to December 2, 2026 for Pekabex's next earnings report. The date gives investors the next scheduled checkpoint for the recovery plan and the order backlog.

Stock valuation and next checkpoint

Pekabex was last quoted at PLN 8.00 on GPW on October 21, 2026 at 4:59 p.m. CEST. Its market capitalization was PLN 198.6 million on the same date, while the 52-week range stood at PLN 7.70 to PLN 15.45.

The stock therefore remained close to its yearly low, while the operating figures pointed to a mixed picture: revenue was stable, the backlog expanded, and the first-half operating result stayed negative. The December reporting date will show whether the stronger second quarter carried into the second half.

The company facts and figures place the contract change in the context of Pekabex's PLN 2.37 billion backlog and first-half operating loss.